Merlin is the product of the
Introduction
Among the ERM (ezrin, radixin, and moesin) family of proteins, merlin, which is encoded by the Neurofibromatosis Type II (NF2) gene, is unique in its ability to suppress cell proliferation and to function as a tumor suppressor (Bretscher et al., 2002) . Indeed, merlin inhibits the proliferation of numerous cell types, and this occurs through its ability to negatively regulate Ras and Rac GTPase signaling (Morrison et al., 2007; Shaw et al., 2001) , to suppress the cell-surface expression of several growth factor receptors by provoking their internalization (Maitra et al., 2006) or degradation (Fraenzer et al., 2003) , or by altering their localization (FernandezValle et al., 2002) . Furthermore, merlin can also prevent the activation of signaling pathways downstream of growth factor receptors (Curto et al., 2007) .
The recent identification of merlin-binding partners has provided insights into how merlin regulates proliferation at so many levels (Scoles, 2008) . Indeed, its binding partners include those that regulate transport (Murthy et al., 1998; Scoles et al., 2006; Shenolikar and Weinman, 2001) , translation (Scoles et al., 2006) , cell-cycle transit (Gronholm et al., 2006) , cell-cell adhesion (Gutmann et al., 1999; Lallemand et al., 2003; Morrison et al., 2001; Obremski et al., 1998) , cytoskeletal organization (Bashour et al., 2002; Manchanda et al., 2005) , and signaling (Kissil et al., 2003; Okada et al., 2005; Rong et al., 2004b) . However, at this juncture it is unclear which of these interactions are essential for merlinmediated inhibition of cell proliferation and tumor growth. Furthermore, the motifs in merlin that direct these interactions are scattered throughout the protein (Scoles, 2008) . Thus, defining which domains of the protein are essential for its growth-suppressive activity should pinpoint those that are necessary for its functions.
Merlin is present in most cell type as two major isoforms, merlin-1 and merlin-2, arising from alternative splicing of exons 16 and 17. Merlin-2 is shorter (590 amino acids), differing from merlin-1 (595 amino acids) beyond amino acid 579. In various types of cells, it has been reported that in contrast to merlin-1, merlin-2 is not able to inhibit proliferation (Sherman et al., 1997) . The differences in the C-terminal sequence prevent merlin-2 from adopting a closed conformation (where the N-terminal and the Cterminal domains are in contact). Therefore, it is generally accepted that merlin-1 is an active growth suppressor when adopting a closed conformation. This notion is supported by the observation that the phosphorylation of serine 518 leads to an open conformation and to the inactivation of merlin-1 (Surace et al., 2004) . Nevertheless, inactivating mutations in NF2 patients occur in all of the first 15 coding exons (up to residue 579), suggesting that all regions of the protein are essential for tumor suppression (Ahronowitz et al., 2007; Baser, 2006) . However, in Drosophila, the larval lethality of Dmerlin mutant flies can be partially rescued by re-expressing the Dmerlin FERM domain (LaJeunesse et al., 1998) , demonstrating that the C-terminal half of the protein is not required for function.
We have recently shown that in Schwann cells (SC), Nf2 inactivation leads to uncontrolled proliferation, which is associated with increased cell-surface expression of the growth-factor receptors ErbB2 and ErbB3. In SC, merlin prevents delivery of these receptors to the cell surface, thus inhibiting downstream mitogenic signaling pathways (Lallemand et al., 2009 ). To identify the domains of merlin that are essential for the inhibition of Schwann cell proliferation, we evaluated the ability of domain-specific mutants of merlin to inhibit proliferation when expressed in Nf2-deficient primary SC. Here, we report that two specific subdomains of merlin are essential for its growth-inhibition functions, the F2 subdomain of the FERM domain and a domain defined by residues 532-579 near the C-terminal region of merlin. Further, we show that these domains are distinct from the actin-targeting region of merlin, which maps to the F1 subdomain. Importantly, we demonstrate that association with actin is not required to inhibit the proliferation of SC, but that it is an important step in the regulation of merlin phosphorylation, which contributes to its tumor-suppressor functions.
Results
The C-terminus of merlin-1 is necessary for inhibition of Schwann cell proliferation
In a remarkable study, Fehon and coworkers showed that the viability and proper development of Dmerlin-deficient Drosophila could be restored by re-expression of the FERM domain alone (LaJeunesse et al., 1998) . Although the efficiency of rescue was higher with longer fragments of Dmerlin containing its C-terminal half, this study showed that, at least in Drosophila, the FERM domain contains most of merlin's activity. However, in mammalian cellular models, phosphorylation of merlin at serine 518, which severs the intramolecular interactions of the C-terminus and the FERM domains, abrogates the function of merlin as a growth inhibitor, suggesting that the C-terminus of merlin plays an essential role in controlling mammalian cell proliferation (Rong et al., 2004a; Surace et al., 2004) .
We have recently shown that inactivation of the Nf2 gene in primary mouse SC results in higher saturation density and the loss of contact inhibition, and that these phenotypes are compensated by re-expression of merlin-1 (Lallemand et al., 2009) . NF2 encodes two alternatively spliced versions, coined merlin-1 and merlin-2, which differ in their C-termini, and merlin tumor suppressor functions were previously ascribed to the better characterized merlin-1 isoform. To test the role of the C-terminal half of merlin-1 on SC growth inhibition, C-terminal deletion mutants of merlin (Fig. 1A) were expressed into Nf2 -/-SC via adenoviral infection, and their ability to rescue the uncontrolled proliferation of Nf2 -/-SC was compared to wild-type merlin-1.
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The expression levels of the truncated variants of merlin-1 were equal or superior to re-expressed merlin-1 and higher than endogenous merlin observed in Nf2 +/+ SC (Fig. 1B) . Remarkably, none of these merlin-1 deletion mutants were capable of restoring proper growth inhibition when cells reached saturation densities, as did Nf2 -/-SC re-expressing wild-type merlin-1 (Fig. 1C) . Therefore, in contrast to Drosophila, the FERM domain of merlin-1 alone cannot inhibit proliferation, and the last 63 amino acids of merlin-1 (532-595) are necessary for this function. The loss of function of these mutants was not due to mislocalization because their subcellular localization overlapped that of merlin-1 (Fig. 1E) . However, in contrast to full-length merlin-1 and the C-terminal half of merlin-1, the C-terminal deletion mutants were detected in the nucleus, which is in accordance with the presence of a nuclear export sequence (NES) in exon 15 of the NF2 gene ( Fig. 1E) (Kressel and Schmucker, 2002) .
Several studies have suggested that of the two major isoforms of merlin, only merlin-1 has tumor-suppressor functions (Bashour et al., 2002; Gutmann et al., 1999; Sherman et al., 1997) . However, using the same assay, we found that merlin-2 also suppressed Nf2 -/-SC proliferation, restoring saturation densities to levels similar to those directed by merlin-1 when expressed at equivalent levels ( Fig.  1D ). These two isoforms only differ in their very last exons, which encode the very C-termini of the two proteins (Hara et al., 1994) . Thus, we conclude that a domain demarked by residues 532-579 (the C-ter47 peptide), the last domain in common for both isoforms, is essential for merlin inhibition of SC proliferation. Finally, because merlin-2 cannot adopt a closed conformation, our data suggest that merlin is able to inhibit growth under an open conformation.
Merlin and ezrin FERM subdomains are not redundant: F2 is necessary for merlin-directed inhibition of proliferation
The expression of only the C-terminal half of merlin-1 had no effect on Nf2 -/-SC growth (Fig. 1C) , but its subcellular localization was different from that of the full-length protein (Fig. 1E ). This suggested that the FERM domain of merlin, although not sufficient, is necessary for growth inhibition, possibly by localizing the full-length protein to the plasma membrane. The FERM domain of merlin, and those of the ERMs, is composed of three very conserved F subdomains that form a cloverleaf structure that is essential for its function (Kang et al., 2002; Shimizu et al., 2002) . To minimize drastic structural alterations of the FERM domain of merlin-1, we tested the role of each F subdomain by generating chimeras between merlin-1 and ezrin, rather than using truncations ( Fig. 2A) . Merlin and ezrin FERM domains are very conserved in sequence (60% identity) and structure but ezrin does not inhibit cell proliferation; rather, ezrin overexpression is associated with invasion and metastasis Yu et al., 2004) . When we substituted the merlin-1 FERM domain with that of ezrin, the resulting chimera (E123.M) failed to inhibit Nf2 -/-SC proliferation (Fig. 2B ,E) despite comparable expression and proper localization to the plasma membrane (Fig.  2C) . Hence, the ezrin FERM domain cannot substitute for the merlin-1 FERM domain for inhibiting SC proliferation.
We then tested the contribution of each F subdomain of merlin-1 by substituting the homologous F subdomain of ezrin, individually or in combination ( Fig. 2A) . The resulting chimeras were expressed in Nf2 -/-SC ( Fig. 2D ) and fell into two groups on the basis of their effects on SC proliferation: those that were capable of inhibiting Nf2 -/-SC uncontrolled proliferation and those that were not (Fig.  2E ). Flow cytometry confirmed that their effect on saturation density was due to the inhibition of proliferation ( Fig. 2F) and not the consequence of enhanced apoptosis, because no cleaved caspase-3 was observed following the expression of these chimeras (Fig. 2G) . Notably, all inactive chimeras had in common the replacement of merlin-1 F2 subdomain ( Fig. 2E and Table 1 ). Therefore, the ezrin F2 subdomain cannot functionally substitute for that found in merlin-1, and the merlin-1 F2 domain is necessary for inhibiting cell proliferation. Importantly, simultaneous replacement of F1 and F3 subdomains of merlin-1 by equivalent subdomains of ezrin, leaving only F2 of merlin-1, yields a growth-suppressive chimera. Thus, the functions of the F1 and F3 subdomains of merlin-1 are redundant with the function of the F1 and F3 subdomains of ezrin. Therefore, we propose that merlin-1 F2 subdomain is essential for directing growth suppression.
The F2 subdomain and C-terminal residues of merlin-1 are necessary for ErbB downregulation in Schwann cells
Merlin-1 regulates the cell-surface expression of the ErbB2 and ErbB3 receptors and thus loss of merlin in Nf2
-/-SC leads to the accumulation of ErbB receptors and the sustained stimulation of downstream mitogenic pathways. As a consequence, Nf2 -/-SC can grow to higher densities (Lallemand et al., 2009 ). Merlin-1 prevents receptor accumulation by limiting their delivery at the plasma membrane. Therefore, we compared the effects of merlin-1, merlin-2 and merlin-1 truncations and chimeras on the expression of ErbB2 and ErbB3 and on the activity of associated signaling pathways. Merlin-1 and merlin-2 were capable of downregulating the expression of ErbB receptors as well as Akt and Stat3 activity. These experiments showed that merlin-1 mutants that were capable of inhibiting Nf2
-/-SC proliferation repressed levels of ErbB2 and ErbB3 and inhibited Stat3 activity, whereas proliferation-inactive merlin-1 mutants did not (Fig. 3) . Most mutants could inhibit Akt activity to some extent and we also observed limited inhibition of MAP kinase activity (not shown). However, these effects appeared to be independent of ErbB downregulation. We did not observe a link between the activity of merlin mutants and that of the Hippo pathway transcriptional coactivator YAP (yes associated protein), as assessed by its nuclear localization (not shown). These findings are consistent with the model in which the F2 subdomain and the C-ter47 sequence of merlin-1 (and merlin-2) mediate inhibition of SC proliferation by promoting the downregulation of the ErbB2 and ErbB3 receptors and of signaling effectors such as Stat3.
F1 and F2 subdomains of merlin-1 are essential for cortical actin association
Under classical fixation and permeabilization conditions (see Materials and Methods for details), merlin-1 shows a marked enrichment at the plasma membrane when overexpressed in Nf2 -/-SC (Fig. 4A, left) . When fixation and permeabilization are performed simultaneously, the Triton X-100-soluble pool of merlin-1 is extracted. Under these conditions, merlin-1 protein appears as a network (Fig. 4A , center and right, and Fig. 4B ) that resembles the cortical actin web, and indeed these two structures largely colocalize (Fig. 4B, lower panels) . Treatment of SC with 5 M latrunculin A, an agent that prevents polymerization of cortical actin, leads to a drastic change in merlin-1 subcellular distribution; rather than colocalizing with actin, merlin-1 instead accumulates as large aggregates at the basal side of the cell ( Fig.  4C and supplementary material Fig. S1 ). Thus, merlin-1 is normally associated with intact cortical actin filaments. Actin binding sites have been described in both F1 and F3 subdomains of merlin-1 and ezrin (Brault et al., 2001; Roy et al., 1997) . Only a subset of the ezrin-merlin-1 chimeras formed a similar network (Fig. 4D , upper six panels). Remarkably, this group corresponds to mutants of merlin-1 that retain either the F1 and F2 subdomains of merlin-1, or the F2 and F3 subdomains of ezrin (Table 1 and supplementary material Fig. S2 ). By contrast, the other mutants and chimeras showed diffuse staining with some bright punctate structures in the cytoplasm (Fig. 4D , lower two panels) and their localization was insensitive to latrunculin A, indicating that they did not associate with cortical actin in the cell (not shown). Our results show that although the F1 subdomain of merlin-1 and the F3 subdomain of Journal of Cell Science 122 (22) 
Summary of growth-inhibition activity, actin association and membraneprotrusion-formation activity of merlin, merlin-ezrin (E1.M, E2.M, E3.M, E1-2.M, E1-3.M, E2-3.M and E1-2-3.M) chimeras, C-terminal (C-ter) deletion mutants of merlin, and C-terminal half of merlin (C-ter merlin). SC, Schwann cells. Fig. 3 . Active merlin-ezrin chimeras downregulate ErbB2 and ErbB3 receptors and associated signaling pathways. Only merlin-1, merlin-2 and merlin-1 mutants having growth-inhibitory activity (E1.M and E1-3.M) triggered downregulation of ErbB receptors and Stat3 signaling, as observed by western blot of total cell extracts 7 days after adenoviral-mediated expression. Most constructs were able to downregulate Akt activity. Actin served as loading control.
ezrin can co-sediment with actin in vitro, they are not sufficient to promote actin colocalization in the cell, which requires the corresponding F2 subdomain. This was confirmed by experiments showing that a fusion protein between merlin F1 and GFP does not localize to cortical actin (not shown). In addition, it appears that the actin-binding site in the F3 subdomain of merlin-1 and the F1 subdomain of ezrin (Brault et al., 2001; Roy et al., 1997) are not sufficient to target the proteins to the cortical actin network in cells.
Finally, these findings demonstrate that the major in vivo actintargeting sites of merlin-1 and ezrin reside within different subdomains of the FERM domain of these proteins.
Actin association is not required for growth inhibition by merlin-1
Recent reports suggest that, at least in liver-derived cells, a mutant of merlin that cannot bind actin is unable to prevent proliferation (Cole et al., 2008; Scoles et al., 2000) . However, analyses show that some of the chimeras that lack the F1 subdomain of merlin-1 and are incapable of localizing to cortical actin still retain the ability to suppress the proliferation of Nf2 -/-SC (Table 1) . In particular, when we compared active chimeras, we could not see any clear difference in the efficiency of growth inhibition among those that can or cannot localize to the cortical actin network. Therefore, at least in primary SC, a target cell affected by familial or sporadic NF2, actin association is not required for the tumor-suppressor functions of merlin.
Localization of merlin-1 to actin facilitates the formation of cortical actin structures Although actin association was not necessary for the tumor suppressor activity of merlin, we reasoned that it might nonetheless regulate the actin network in primary SC. Indeed, overexpression of merlin-1 domains in cells often triggers the formation of actin-enriched cortical structure (Shaw et al., 1998; Surace et al., 2004) . When expressed in SC, merlin-1 induced the formation of short membrane protrusions (Fig. 5, top row) . Further, chimeras that were capable of inducing such structures were those that colocalized with cortical actin (Fig. 5 , Table 1 and supplementary material Fig. S3 ). This pinpointed the F1 subdomain of merlin-1 as being required for the formation of 5 . The F1 subdomain of merlin-1 is necessary but not sufficient to promote membrane protrusions in primary SC. Expression of merlin-1 and actin-associated chimeras (such as E2-3.M) in Nf2 -/-SC triggered the development of small filamentous structures at the membrane, whereas chimeras in which the F1 subdomain of merlin-1 was lacking (like E1.M or E1-3.M) could not. The left panels show epifluorescence imaging of the staining of merlin-1 and chimeras with or without the F1 subdomain Scale bars: 2m. Center panels display an enlargement of the section delimited by a white square in the left panels. Scale bars: 0.5m. Right panels show membrane structures corresponding to the middle panels visualized by staining with 10M AlexaFluor-555-labeled wheat germ agglutinine (WGA). Scale bars: 0.5m. Additional images of other constructs are provided in supplementary material Fig. S3 . these membrane protrusions. SC expressing chimeras unable to associate with actin did not show prominent structures when the cell surface was stained with AlexaFluor-555-labeled wheat germ agglutinin (Fig. 5, lower two rows) . Therefore, remodeling of cortical actin and formation of membrane structures require association of merlin-1 to actin but are independent of its growth inhibition activity. Interestingly, only expression of merlin-1 or merlin-2 was capable of restoring, to some extent, a cellular morphology close to the bipolar shape displayed by wild-type SC (see Fig. 4A ).
Actin association modulates the phosphorylation and activity of merlin-1
When phosphorylated on serine 518, merlin-1 can no longer inhibit proliferation in various cell lines (Surace et al., 2004) . Indeed, we confirmed that a mutant of merlin with a substitution of serine 518 by an aspartic acid residue, which mimics constitutive phosphorylation, could no longer efficiently inhibit proliferation of primary SC (Fig. 6A) . By contrast, SC growth was impaired when a merlin mutant with a substitution of serine 518 by an alanine, leading to a constitutively unphosphorylated protein, was expressed (Fig. 6A ). PAK1/2 and PKA are major kinases of serine 518 (Alfthan et al., 2004; Kissil et al., 2002; Xiao et al., 2002) and we therefore tested whether the failure of some of the chimeras to inhibit growth was due to increased phosphorylation of serine 518. The phosphorylation state of the chimeras was assessed by western blotting using an antibody that specifically recognizes this phosphorylated site. We observed that the lack of growth-inhibition activity was not a consequence of an increase in serine 518 phosphorylation (Fig. 6B) . However, chimeras that colocalized with actin clearly showed elevated levels of phosphorylated serine 518 compared with chimeras that could not. Indeed, two chimeras, E3.M and E2-3.M, were proportionally more phosphorylated than wild-type merlin-1 (Fig. 6B) , and these chimeras retained the F1-actin-localization domain of merlin-1 and the F3 subdomain of ezrin, which also contributes to actin association. In addition, when SC were treated with latrunculin A or cytochalasin D, two agents that disrupt actin filaments, merlin-1 was less efficiently phosphorylated in response to serum stimulation (Fig. 6C) . Therefore, localization of merlin-1 with the cortical actin network facilitates phosphorylation of serine 518, possibly by promoting its localization close to PAK and PKA kinases.
Discussion
Merlin-1 is an actin-binding protein with anti-proliferative activity that is regulated by phosphorylation. Our study identifies two domains of merlin-1 that are essential for its ability to inhibit the proliferation Nf2 -/-SC, residues 532-579 (C-ter47 peptide) and the F2 subdomain of the FERM domain (Fig. 7) . Analyses of the spectrum of mutations in NF2 patients have revealed that inactivating mutations are not found in exons 16 and 17 (Baser, 2006; Jacoby et al., 1996) . This observation strongly suggests that such mutations would have no effect on merlin tumor-suppressor activity and this might explain why merlin-1 and merlin-2, which are identical up to amino acid 579, have growth-inhibitory activity when expressed in Nf2 -/-SC. Hence, residues 532-579 appear essential for the inhibition of proliferation and thus for the tumorsuppressor functions of merlin. However, it remains to be explained why, in some cellular models, merlin-2 does not inhibit cell proliferation (Bashour et al., 2002; Sherman et al., 1997) . -/-SC compared with Nf2 -/-SC expressing merlin-1 S518A or S518D (***P<0.001; n/s, not significant). The relative levels of re-expression of the two mutants was evaluated by western blot. (B)Western blot analysis of the phosphorylation level of the different ezrin-merlin-1 chimeras is shown in comparison to merlin-1. The western blot at the top was incubated with an anti-merlin antibody (merlin-1). The western blot at the bottom was incubated with an antibody specific to the phosphorylated form of merlin on serine 518 (p-merlin 518 ). Quantification of the ratio of phosphorylated to total merlin-1 is shown in the bar graph. (C)Phosphorylation of merlin-1 on serine 518, 30 minutes after stimulation by 10% FBS in SC treated for 90 minutes with latrunculin A (5M) or cytochalasin D (1M). Quantification shown presents the ratio of phosphorylated merlin-1 in treated cells relative to untreated cells. Fig. 7 . Model of the functional domains of merlin-1. The F2 subdomain of the FERM domain of merlin-1and the C-ter47 peptide (532-579) are required for the growth-inhibition activity of merlin-1. F1 and F2 subdomains are necessary for cortical actin association and membrane protrusions, although two F-actin binding domains have been identified in F1 (residues 1-27) and F3 (residues 280-323). Association to actin via F1-F2 is not required for the inhibition of growth by merlin-1. Nevertheless, it facilitates phosphorylation of serine 518 and therefore participates in the regulation of the growth-inhibition activity of merlin-1. Identification of merlin functional domains Interestingly, two well-characterized dominant-negative forms of merlin both harbor deletions in the F2 subdomain, the 'blue-box' and the 'delta exons 2-3 mutants', which are both capable of overcoming endogenous merlin activity in vivo (Giovannini et al., 1999; Johnson et al., 2002; LaJeunesse et al., 1998) . These findings support our conclusions that the F2 subdomain plays a crucial role in growth inhibition. Strikingly, structural and biochemical studies of merlin-1 have suggested that the F2 subdomain and the Cterminal end are in contact when the protein is hypophosphorylated and in its closed conformation (Li et al., 2007; Sherman et al., 1997) . As the closed conformation is proposed to be the active form of merlin-1, it is possible that interaction of the F2 subdomain and the C-terminus might form a functional domain that directs growthinhibitory activity. However, this interpretation contradicts studies that show that this conformation masks the binding sites for several partners of merlin (Gonzalez-Agosti et al., 1999; Gutmann et al., 2001; Neill and Crompton, 2001) . Notably, most interacting proteins have been found by pull-down assay or two-hybrid screens using either the FERM domain or the C-terminal half of merlin alone as a bait; scenarios that mimic the open conformation Manchanda et al., 2005; Neill and Crompton, 2001; Sainio et al., 1997) . Combined with our own data showing that merlin-2, which is always in an open state, is capable of inhibiting proliferation, these observations strongly suggest that, to inhibit proliferation, merlin-1 needs to be in an open conformation that exposes the F2 and C-terminal domains for binding to their partners. In such a scenario, we predict that phosphorylation of merlin-1 on serine 518 inhibits its activity by compromising the interaction of essential partners with its C-terminal domain (Rong et al., 2004a) . Merlin-mediated downregulation of the ErbB2 and ErbB3 receptors is essential for inhibiting the growth of Nf2 -/-SC (Lallemand et al., 2009 ). Thus, the binding partners involved in the transport or degradation of these receptors might play key roles in this response. Merlin-1 interacts with ErbB2 (Fernandez-Valle et al., 2002) , and the F2 subdomain represents an interesting motif that might mediate this interaction, either directly or by binding to another partner. One regulator of this response could be HRS (hepatocyte growth-factorregulated tyrosine kinase substrate), which is necessary for merlinmediated inhibition of proliferation (Sun et al., 2002) and which regulates EGFR internalization and degradation and blocks proliferation of schwannoma cells, even in the absence of merlin (Scoles et al., 2005; Sun et al., 2002) . Interestingly, HRS binds to residues 453-557 of merlin, a region that is also essential for its activity Scoles et al., 2000) . It remains to be clarified whether HRS promotes downregulation of ErbB2 and ErbB3 in SC. Growth inhibition of SC was also correlated to the inhibition of Stat3 activity which, interestingly, is known to be regulated by merlin, HRS and ErbB2 (Scoles et al., 2002; Ren et al., 2002) . We also observed that Akt was downregulated by merlin and merlin chimeras, but this was not sufficient to inhibit SC proliferation. Nevertheless, this result does not exclude the possibility that inhibition of Akt activity is required for growth arrest by merlin.
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Two studies have shown that the first 20 N-terminal residues of merlin can bind actin in vitro (Brault et al., 2001; Cole et al., 2008) . Our experiments indicate that the merlin-1 F1 subdomain is necessary but not sufficient for cortical actin targeting in SC, and that the merlin-1 F2 subdomain is required for F1 to colocalize with actin in vivo (Fig. 7) . Here, F2 might contribute indirectly, through interactions with other actin-binding partners or, alternatively, the entire structure of the F1-F2 segment could be essential to target merlin to cortical actin. Furthermore, we show that the putative second actin-binding region in the F3 subdomain is not sufficient to allow merlin-1 to associate with the cortical actin in SC. Study of the merlin-ezrin chimeras also indicates that the ezrin FERM domain can associate actin via the F2-F3 segment (E1-2.M does not localize to actin, whereas E2-3.M does). In this case, the actinbinding site identified between residues 280 and 320 (Roy et al., 1997) is not sufficient for proper localization of ezrin in SC and requires additional sequences of the F2.
Nf2 -/-SC have very few actin-rich membrane protrusions, yet expression of merlin-1 in these cells leads to the formation of short filamentous cytoplasmic extensions. We observed these only in mutant or chimeric forms of merlin-1 that retained their F1 subdomain; thus, association of merlin-1 to actin via the F1 subdomain is necessary for the formation of membrane protrusions. By contrast, the C-terminal half of merlin-1 is not necessary for this response (Fig. 7) . However, a recent study has shown that a phosphomimetic S518D mutant of merlin can induce filipodial extensions (Surace et al., 2004) . Therefore, phosphorylation of serine 518 might augment this response, for example by unmasking other interaction motifs within the FERM domain.
Importantly, we find no correlation between actin colocalization and inhibition of proliferation by merlin-1. Indeed, some of the ezrin-merlin-1 chimeras localized with actin yet failed to inhibit SC growth (E2.3M), whereas others that were able to inhibit proliferation failed to localize with cortical actin (E1M). Therefore, colocalization with actin is not necessary for this key tumorsuppressor function of merlin. The failure of merlin-1 to bind to cortical actin does not, however, necessarily preclude its interactions with membrane-associated partners, as was described for the L64P merlin mutant (Lallemand et al., 2003) . Remarkably, a recent study showed that truncation of the first 18 amino acids of merlin-1 (Nf2
18-595
) in liver-derived cells abrogates both actin localization and the inhibition of proliferation (Cole et al., 2008) . In this cell type, merlin-1 inhibits proliferation by blocking EGFR activity. By contrast, our studies show that merlin-1-mediated growth inhibition of primary SC, the physiologically relevant target of merlin tumorsuppression, appears to be due to the suppression of ErbB2 and ErbB3 expression and associated signaling. In support of this hypothesis, we observed that when expressed in primary Nf2 -/-SC, Nf2 18-595 was able to inhibit proliferation and downregulate ErbB2 and ErbB3 expression (data not shown).
The phosphorylation of merlin-1 on serine 518 in response to serum stimulation is impaired when merlin-1 is not associated to actin. This finding agrees with those of others who have demonstrated that mutations of the FERM domain of merlin that prevent actin association also impair the phosphorylation of merlin on serine 518 by PAK2 (Rong et al., 2004a) . Indeed, though our data demonstrate that localization to actin is not required for tumorsuppressor activity, actin association clearly affects this modification of merlin-1 (Fig. 7) . It is probable that the stable localization of merlin-1 at the plasma membrane via its F1 subdomain facilitates interactions with its kinases PAK and PKA, which are present and activated in this compartment (Gronholm et al., 2003; Lu and Mayer, 1999) . Interestingly, two recent studies have shown that merlin is also phosphorylated on serine residues localized within its first 18 N-terminal amino acids (Cole et al., 2008; Laulajainen et al., 2008) . Phosphorylation of one serine (serine 10) by PKA did not affect merlin localization and had no impact on phosphorylation of serine 518 (Laulajainen et al., 2008) . On the other end, phosphorylation of four serine residues (serines 7, 10, 12 and 13), decreased merlin localization at the plasma membrane (Cole et al., 2008) . Therefore, merlin-1 C-terminal phosphorylation and growth-suppressive activity might be coordinated with N-terminal phosphorylation, notably by PKA. Finally, our results suggest that changes in the organization and dynamics of cortical actin modulate merlin phosphorylation and activity. Thus, merlin probably constitutes an essential factor in the functional feedback loop connecting cortical actin dynamics to cell proliferation.
Materials and Methods

Schwann cell cultures and treatments
Primary mouse SC were cultured from sciatic nerves of adult Nf2 flox/flox mice (Giovannini et al., 2000) . P75-mediated magnetic cell sorting was used to purify SC (Manent et al., 2003) . SC were routinely cultured in N2 media [DMEM-F12 with 2 M forskolin, 10 ng/ml heregulin, 50 g/ml gentamicin, 2.5 g/ml fungizone and N2 supplement (Gibco)]. Nf2 deletion in SC was achieved by infection with a Cre recombinase-expressing adenovirus (Ad5CMV-Cre, University of Iowa Gene Transfer Vector Core, Iowa City, IA). Recombination (>90%) was assessed by western blot and PCR analysis (not shown). For each experiment, control SC were infected with either an empty adenovirus or an adenovirus expressing b-galactosidase.
To assess saturation density, SC were seeded at 50,000 cells/cm 2 and infected with the corresponding adenovirus for 24 hours. Cells were counted after 10 days in culture, at which point Nf2 -/-SC had reached saturation density. For each construct tested, four individual cultures were counted each time. Experiments were repeated at least three times with independent primary SC cultures.
To assess merlin phosphorylation, SC were deprived of growth factors for 24 hours. After 90 minutes of latrunculin A (5 M) or cytochalasin D (1 M) treatment, cells were stimulated with 10% FBS for 30 minutes in the presence of latrunculin A or cytochalasin D (Sigma) and collected for total cell extract preparation.
Expression constructs, deletion mutants and merlin-ezrin chimeras
C-terminal deletion mutants of merlin-1 were generated by PCR amplification with a reverse primer incorporating a stop codon at the desired position. The C-terminal half of merlin-1 was generated by PCR amplification from merlin-1 cDNA generating an ATG in front of codon 990. Merlin-ezrin chimeras were generated by annealing PCR fragments corresponding to the various F subdomains at a position where there was conservation of amino acid sequence between merlin and ezrin. E1.M, E1-2.M and E1-2-3.M were generated by PCR amplification of the desired fragments of merlin-1 and ezrin, including compatible restriction sites in the primers (ezrin-merlin junction sequences were as follows: E1.M, KFRGAKF; E1-2.M, KIINLE; E1-2-3.M, EKKNSMR). E3.M was generated by PCR amplification and ligation of the fragments, incorporating compatible restriction sites, corresponding to the first two subdomains of merlin-1 (residues 1-211) and a fragment of E1-2-3.M containing F3 of ezrin (residues 196-327 ) and the C-terminal half of merlin-1 (residues 342-595) (F2merlin-F3ezrin junction sequence was QDVDMY). E1-3.M was generated by PCR amplification and ligation of the fragment, incorporating compatible restriction sites, corresponding to the first two subdomains of E1.M constructs and the fragment of E1-2-3.M containing F3 of ezrin (residues 195-327) and the C-terminal half of merlin-1 (residues 342-595) (F2ezrin-F3merlin junction sequence was as in E1.M and E3.M). E2-3.M was generated by PCR amplification and ligation of the fragments, incorporating compatible restriction sites, corresponding to the first subdomain of merlin-1 (residues 1-98) and a fragment of E1-2-3.M containing F2 and F3 of ezrin (residues 83-327) and the C-terminal half of merlin-1 (residues 342-595) (F1merlin-F2ezrin junction sequence is HFGAKFY). E2.M was generated by PCR amplification and ligation of the fragment, incorporating compatible restriction sites, corresponding to the first subdomain of merlin-1 and the fragment of E1-2.M containing F2 of ezrin (residues 83-195), F3 and the C-terminal half of merlin-1 (residues 211-595) (ezrinmerlin junction sequences were as in E2-3.M and E1-2.M). Nf2S518A, and Nf2518D mutants were created by site-directed mutagenesis of mouse Nf2 isoform 1 (QuickChange, Stratagene). All cDNAs were subsequently cloned into pAdEasy-1 vector from Stratagene.
Adenoviral vectors and infections
Adenoviruses were prepared with the AdEasy system (Stratagene) according to the manufacturer's instructions. Efficiencies of infection were assessed by indirect immunofluorescence. Experiments were performed when infection efficiency was superior to 90%. 
Immunoblotting
Total cell extracts were prepared with an extraction buffer [50 mM Tris pH 7.4, 1% Triton X-100, 0.2% SDS, 150 mM NaCl, 1 mM EDTA, 2 mM PMSF, 1 mM NaVO 4 , 10 mM b-glycerophosphate and protease inhibitors cocktail (Pierce)]. Following clarification of the extracts by centrifugation (20,000 g for 10 minutes at 4°C), protein concentration was measured by Bradford assay (BioRad). For western blotting, proteins were separated by SDS-PAGE and transferred to nitrocellulose. Membranes were incubated with primary antibodies overnight at 4°C in PBS, 0.1% Tween and 5% nonfat dry milk or in PBS, 0.1% Tween 20 and 2% BSA for phospho-specific antibodies.
Immunofluorescence
To assess localization of merlin-1, merlin-1 mutants and chimeras, SC were fixed on glass coverslips for 20 minutes in 4% formaldehyde, permeabilized in PBS containing 0.2% Triton X-100 for 10 minutes and incubated overnight at 4°C with the primary antibody in PBS containing 0.1% Tween and 10% FCS, followed by 2 hours at room temperature with secondary antibody (Amersham Bioscience). Samples were then mounted on a glass slide with Citifluor mounting media. Staining of SC membrane structure was performed with AlexaFluor-555 wheat germ agglutinin at 10 g/ml in PBS for 1 hour at room temperature.
To visualize merlin-1 colocalization with cortical actin, SC were fixed in HEPES buffer (50 mM pH 7.4) with 4% formaldehyde and 0.2% Triton X-100 for 20 minutes. Incubations with antibodies were performed as above. Actin was visualized with rhodamine-labeled phalloidin (Molecular Probes). Pictures were acquired using a Leica DM 6000B epifluorescence microscope and a 63ϫ oil immersion objective.
FACS analysis
For FACS analyses, Nf2 -/-SC were plated at 50,000 cells/cm 2 and infected with the corresponding adenovirus for 24 hours. Cells were left in N2 culture media for 5 days until they reached saturation density and labeled with BrdU (10 mM, 4 hours), then collected and processed according to the manufacturer (Becton-Dickinson). Briefly, cells were fixed in 70% ethanol and treated with 2 N HCl in 0.5% Triton X-100. After neutralization with 0.1 M Na 2 B 4 O 7 (pH 8.5), SC were sequentially incubated with an anti-BrdU antibody (Becton-Dickinson; 30 minutes) and FITCconjugated horse anti-mouse secondary antibody (Vector Laboratories; 30 minutes). Cells were resuspended in PBS containing 40 g/ml propidium iodide and RNAse. Analysis was performed with CellQuest software (Becton-Dickinson).
Statistical analysis
Statistical analysis was performed using Prism 4 software (GraphPad Software). Results are reported as mean ± s.d. Experiments were repeated at least three times. Data were analyzed by unpaired Student's t-test and differences were considered significant when P<0.05 (***P<0.001, **0.001<P<0.01, *0.01<P<0.05).
